Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin + BEAM/BEAC in Mantle Cell Lymphoma
NCT00514475Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Nov 2005
- Primary completion
- Jun 2009
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in mantle cell lymphoma (MCL), sponsored by Oslo University Hospital. Started Nov 2005; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00514475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514475.